Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Hypertension Due to Lung Diseases”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Not applicableNot Yet RecruitingNCT05464238
What this trial is testing

Training in HFpEF-PH

Who this might be right for
Pulmonary Hypertension Due to Left Heart DiseaseHeart Failure With Preserved Ejection Fraction
Heidelberg University 90
Large-scale testing (Phase 3)Study completedNCT02630316
What this trial is testing

Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE

Who this might be right for
Pulmonary HypertensionInterstitial Lung DiseaseCombined Pulmonary Fibrosis and Emphysema
United Therapeutics 326
Testing effectiveness (Phase 2)WithdrawnNCT03012646
What this trial is testing

Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPD

Who this might be right for
Pulmonary HypertensionChronic Obstructive Pulmonary Disease
United Therapeutics
Not applicableLooking for participantsNCT07777367
What this trial is testing

Exercise Performance on Ambient Air vs. Low-Flow Liquid Oxygen Therapy in Chronic Lung Diseases

Who this might be right for
Pulmonary Vascular DiseaseChronic Thromboembolic Pulmonary Hypertension (CTEPH)Pulmonary Arterial Hypertension (PAH)
Silvia Ulrich Somaini 40
Not applicableActive Not RecruitingNCT03611270
What this trial is testing

TReatment of Pulmonary Hypertension Group II Study

Who this might be right for
Pulmonary Hypertension (PH) Due to Left Heart Disease
SoniVie Inc. 15
Not applicableLooking for participantsNCT04808596
What this trial is testing

Pulmonary Hypertension Biorepository and Registry

Who this might be right for
Pulmonary HypertensionPulmonary Arterial HypertensionPulmonary Hypertension Due to Left Heart Disease+6 more
University of Kansas Medical Center 300
Large-scale testing (Phase 3)Ended earlyNCT00458276
What this trial is testing

Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery

Who this might be right for
Heart DiseasesHypertension, Pulmonary
Idorsia Pharmaceuticals Ltd. 274
Testing effectiveness (Phase 2)Study completedNCT02070991
What this trial is testing

Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction

Who this might be right for
Pulmonary Hypertension
Actelion 63
Testing effectiveness (Phase 2)Study completedNCT01862536
What this trial is testing

Tadalafil for Pulmonary Hypertension Due to Chronic Lung Disease

Who this might be right for
Pulmonary HypertensionChronic Obstructive Pulmonary Disease (COPD)
VA Office of Research and Development 44
Testing effectiveness (Phase 2)Study completedNCT04945460
What this trial is testing

Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)

Who this might be right for
Hypertension, Pulmonary
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 165
Post-approval studies (Phase 4)Looking for participantsNCT07322133
What this trial is testing

Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE)

Who this might be right for
Hypotension and ShockPulmonary Hypertension of the Newborn (PPHN)Hypoxemic Respiratory Failure
University of California, Davis 30
Not applicableLooking for participantsNCT06388421
What this trial is testing

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Who this might be right for
Pulmonary Hypertension Due to Lung Diseases and HypoxiaPulmonary HypertensionInterstitial Lung Disease
United Therapeutics 900
Testing effectiveness (Phase 2)WithdrawnNCT04882774
What this trial is testing

Telemonitoring to Treat Group 2 Pulmonary Hypertension

Who this might be right for
Pulmonary Hypertension Due to Left Heart Disease
Mardi Gomberg -Maitland MD, MSc
Testing effectiveness (Phase 2)Looking for participantsNCT06336798
What this trial is testing

Bioenergetic Effect of Pioglitazone in CLD-PH

Who this might be right for
Pulmonary HypertensionPulmonary Hypertension Due to Lung Diseases
Emory University 20
Testing effectiveness (Phase 2)Study completedNCT00759408
What this trial is testing

The Role of Endothelin in Pulmonary Hypertension

Who this might be right for
Pulmonary Hypertension
Brigham and Women's Hospital 38
Post-approval studies (Phase 4)Study completedNCT00862043
What this trial is testing

Sildenafil for Secondary Pulmonary Hypertension Due to Valvular Disease

Who this might be right for
Pulmonary HypertensionValvular Heart Disease
Hospital General Universitario Gregorio Marañon 200
Not applicableWithdrawnNCT05205265
What this trial is testing

Rivet PVS Therapy in Group 2 PH-HFpEF

Who this might be right for
Heart FailurePulmonary Hypertension
NXT Biomedical
Early research (Phase 1)Study completedNCT06048120
What this trial is testing

Learn How Safe the Study Treatment BAY2701250 is, How it Affects the Body and How it Moves Into, Through and Out of the Body in Healthy Male Participants When a Single Amount is Given as an Injection Into the Vein (Intravenous Infusion) or Under the Skin (Subcutaneous Injection)

Who this might be right for
Pulmonary Hypertension Due to Left Heart Disease
Bayer 82
Large-scale testing (Phase 3)Ended earlyNCT03496623
What this trial is testing

Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary HypertensionChronic Obstructive Pulmonary Disease
United Therapeutics 188
Testing effectiveness (Phase 2)Looking for participantsNCT07473700
What this trial is testing

Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease

Who this might be right for
Hypertension, PulmonaryLung Diseases, Interstitial
Tectonic Operating Company, Inc. 25
Next Page